Programme Committee

  • Hans Wigzell, Karolinska Institutet (Chairman)
  • Stephen Groft, Director, Office of Rare Diseases, NIH
  • Jan-Inge Henter, Childhood Cancer Research Unit, Karolinska University Hospital
  • Leena Peltonen-Palotie, Dept of Medical Genetics, University of Helsinki, Department of Molecular Medicine, National Public Health Institute, Finland & Gordon and Virginia MacDonald Distinguished Chair in Human Genetics, UCLA
  • Kerstin Westermark, Medical Products Agency, Sweden, COMP-member, Dept of Internal Medicine, Uppsala University Hospital